Back to search

Article

LCP1 is a potential prognostic biomarker and correlates with immune infiltration in triple negative breast cancer

2024-03-28

Abstract excerpt

<h4>Objective: </h4> Triple-Negative Breast Cancer (TNBC), known for its aggressiveness and treatment challenges due to the absence of ER, PR, and HER2 receptors, is the focus of this study. The research emphasizes the need for new biomarkers like LCP1 (Lymphocyte cytosolic protein 1), which plays a crucial role in cell processes and immune cell activity, to predict outcomes and guide treatments in TNBC. Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c719d38-fef3-5989-abd6-483bf1dd0314
DOI
10.21203/rs.3.rs-4090958/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
LCP1 is a potential prognostic biomarker and correlates with immune infiltration in triple negative breast cancerDOI 10.21203/rs.3.rs-4090958/v1
Select a neighboring publication to make it the new centre.